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Anincreasinglypopularandpromisingﬁeldinfunctionalproteomicsistheisolationofproteomesubsetsbasedonsmallmolecule-
protein interactions. One platform approach in this ﬁeld are Capture Compounds that contain a small molecule of interest to
bind target proteins, a photo-activatable reactivity function to covalently trap bound proteins, and a sorting function to isolate
captured protein conjugates from complex biological samples for direct protein identiﬁcation by liquid chromatography/mass
spectrometry (nLC-MS/MS). In this study we used staurosporine as a selectivity group for analysis in HepG2 cells derived
from human liver. In the present study, we combined the functional isolation of kinases with diﬀerent separation workﬂows of
automated split-free nanoﬂow liquid chromatography prior to mass spectrometric analysis. Two diﬀerent CCMS setups, CCMS
technology combined with 1D LC-MS and 2D LC-MS, were compared regarding the total number of kinase identiﬁcations. By
extending the chromatographic separation of the tryptic digested captured proteins from 1D LC linear gradients to 2D LC we
were able to identify 97 kinases. This result is similar to the 1D LC setup we previously reported but this time 4 times less input
materialwasneeded.ThismakesCCMSofkinasesanevenmorepowerfultoolfortheproteomicproﬁlingofthisimportantprotein
family.
1.Introduction
Kinases play a pivotal role in cell signaling and human devel-
opment and diseases, and they are, therefore, a major focus
of proteomics research. The low abundance, particularly
of protein kinases, makes direct detection of kinases from
biological samples a challenging feat. Recently, techniques
based on small molecule-protein interactions for the func-
tional enrichment of protein families have been developed
[1, 2]. We recently reported the functional isolation of
kinases from complex biological mixtures using a kinase-
speciﬁctrifunctionalCaptureCompound(Figure 1)withthe
broadband kinase inhibitor staurosporine as the selectivity
function [1].
The general design of Capture Compounds consists
of three main functionalities (Figure 1(a)): (a) a selectiv-
ity function, in this case the ATP mimetic kinase inhibitor
staurosporine, (b) an adjacent photoreactive functionality
for photocrosslinking, and (c) a sorting function, for exam-
ple, biotin, for the isolation of captured proteins [3–5]. In
ordertodeterminethekinasesinteractingwithstaurosporine
in a given biological sample, ﬁrst, incubation leads to an
equilibrium binding based on aﬃnity between the Capture
Compound and the proteins (Figure 1(b)). This equilibrium
is then frozen by a photochemical reaction leading to the
formation of a covalent bond between the Capture Com-
poundandtheinteractingproteins.Additionofstreptavidin-
coated magnetic beads allows isolation of the CC-protein
conjugates via the biotin sorting function of the CC. Isolated
proteinsaretrypticallydigestedonbead,andthesupernatant
containing tryptic peptides is then identiﬁed by nanoﬂow
liquid chromatography/tandem mass spectrometry (nLC-
MS/MS). To discriminate between background proteins
and speciﬁc interaction partners of the selectivity group,2 Journal of Biomedicine and Biotechnology
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Figure 1: The molecular structure of staurosporine Capture Compound (a) and schematic representation of the capture process (b).
a parallel experiment is carried out in which the lysate is ﬁrst
preincubated with staurosporine (competition experiment).
Proteins only present in the capture assay, but not (or
signiﬁcantly weaker) in the competition control, are speciﬁc
interactors of staurosporine.
Previously, we enriched in one CCMS from 400μgo f
cell lysate as starting material approximately 20 kinases in
a single run of the experiment. The number of proteins
annotatedaskinaseswasincreasedbyrepetitiveperformance
of the capture experiments followed by 1D nLC-MS/MS
runs. However, this was only possible by increasing the
amount of required biological material at the same time [1].
Due to the identiﬁcation of additional unspeciﬁc proteins
during the capture experiment, we asked ourselves whether
the number of speciﬁcally enriched kinases can be raised
by changing chromatographic conditions to either a longer
linear gradient or even to a combination of two diﬀer-
ent chromatographic separation methods. Multidimensional
chromatography was applied to our CCMS technology to get
more information about the detection limit of our CCMS
technology. In this study, we demonstrate that a much higher
number of kinases is speciﬁcally captured and identiﬁed by
combining CCMS with 2D LC in comparison to 1D LC and
keeping the same low amount of input material. Moreover,
the conﬁdence with which each kinase could be identiﬁed
was increased by getting a higher number of spectral counts
per protein. Performing relative quantiﬁcation based on
spectral counts of identiﬁed proteins from assay versus
competition experiments reﬂects directly the detection limit
of our CCMS technology. The potential of the CCMSJournal of Biomedicine and Biotechnology 3
technology is signiﬁcantly enhanced by combining capture
experiments with 2D LC-MS/MS analysis.
2.MaterialsandMethods
The HepG2 cell line was purchased from the German
collection of microorganisms and cell lines (DSMZ) and
growth and lysate preparation was contracted to InVivo
BioTech (Berlin, Germany). Cells were lysed in cell opening
buﬀer (6.7mM MES, 6.7mM NaOAc, 6.7mM HEPES,
1mM EDTA, 10mM β-mercaptoethanol, 200mM NaCl, pH
7.5, Roche Complete Protease Inhibitor EDTA free) and
homogenized three times in a French press (>50,000 and
<150,000kPa). Debris was removed by centrifugation. To
remove free ATP as well as other small molecules from
the supernatant, the HepG2 lysate was dialysed with a
molecular weight cut oﬀ of 6–8kDa overnight. Protein
concentrations were determined by the Bradford assay [2].
Naturally biotinylated proteins were removed from the
HepG2 cell lysates by preclearing with streptavidin-coated
magnetic beads.
Capture experiments were carried out as previously
described [1]. Brieﬂy, in one capture assay or competition
control, respectively, 400μg protein of precleared HepG2
cell lysate was supplemented with 5x capture buﬀer. To
the competition reaction, 20μL of 1mM staurosporine
competitor was added, while to the capture reaction an equal
volume of water was added. After incubation for 2h at 4◦C,
theCCwasadded(10μLofa50μMsolutioninwater)giving
a ﬁnal reaction volume of capture assay and competition
control of 100μL, respectively. Samples were then irradiated
for 10min at 4◦C at using the caproBox, a device for the
controlled irradiation of biological samples. The maximal
irradiation is at λ = 312nm, and a UV ﬁlter with a cutoﬀ
below λ = 330nm was applied. The covalently cross-linked
protein-CCconjugateswerethenincubatedwithstreptavidin
coated magnetic beads. The beads were washed successively
withwashbuﬀer,80%acetonitrile/water,andwater.Washing
steps were carried out using the caproMag, a device for
handling magnetic beads. Isolated proteins were tryptically
digested as described (Luo et al. [6]). We carried out two sets
of biological replicates, each set consisting of 3 capture assay,
and 3 competition controls. The three replicates were then
analyzed either by 1D LC-MS/MS (90min gradient), 1D LC-
MS/MS (180min gradient), or 2D LC-MS/MS.
Tryptic digests were analyzed on a LTQ-Orbitrap XL
instrument online coupled to an EASY-nLC system (Ther-
moScientiﬁc, Bremen, Germany). 1D chromatographic pep-
tide separation was performed on a reversed phase (RP)
precolumn (5cm, 100μm, 100 ˚ A) connected to an RP
analytical column (15cm, 75μm, 100 ˚ A) using either a
90min or 180min gradient (0–35% acetonitrile, 0.1%
formic acid). In the 2D LC approach, samples were ﬁrst
loaded onto a biphasic strong cation-exchange SCX/RP
precolumn (3.5cm, 150μm) and eluted with 5 succes-
sive salt steps (50mM–100mM–150mM–250mM–500mM
ammonium acetate (8μL each)) onto a RP for subse-
quent peptide separation using a 120min linear gradient.
Mass spectrometric detection was performed in the data-
dependent mode allowing to automatically switch between
Orbitrap-MS and LTQ-MS/MS (MS2) acquisition. The most
intense ions (up to ﬁve, depending on signal intensity) were
sequentially isolated for fragmentation in the linear ion trap
using collisionally induced dissociation (CID) at a target
value of 10,000 charges. Target ions, already mass selected
for CID, were dynamically excluded for the duration of 60s.
The minimal signal required for MS2 was 500 counts. An
activation q of 0.25 and an activation time of 30min were
applied for MS2 acquisitions.
All MS/MS data were analyzed using SEQUEST imple-
mented in Bioworks Browser 3.3.1 SP1 (Thermo Fisher
Scientiﬁc) and X!Tandem (http://www.thegpm.org/;v e r -
sion 2007.01.01.1, Proteome Software, Portland, Ore,
USA). Automated database searching against the human
UniProtKB/Swiss-Prot database (release 2010 07 contains
517 802 sequence entries and human entries) was performed
with 5ppm precursor tolerance, 1amu fragment ions toler-
ance, and full trypsin speciﬁcity allowing for up to 2 missed
cleavages. Methionine oxidation was used as ﬁxed and phos-
phorylation as variable modiﬁcation in the database search.
Spectra were annotated via human UniProtKB/Swiss-
Prot database and analyzed using the software Scaﬀold
(version Q+ 3 00 02, Proteome Software, Portland, Ore,
USA). First Proteins were selected if the peptide probability
was ≥95% assigned by the Peptide Prophet algorithm
[3], and the protein was identiﬁed by at least 2 unique
peptides. The estimated false discovery rate of peptide
identiﬁcations was determined using the reversed protein
database approach and was ≤1%. Subsequently, the spectra
of kinases identiﬁed by only one unique peptide with ≥95%
were manually validated (Supplementary Figures available at
doi: 10.1155/2011/850589). Gene ontology annotation was
carried out for all identiﬁed proteins via BioMart on the
Ensembl web site (http://www.ensembl.org) using the build
Ensembl58HomosapiensGRCh37.Allgeneontologieswere
then manually validated via SwissProt, and only proteins
annotated as kinases in both databases were accepted.
3. Results
We carried out CCMS experiments in HepG2 whole cell
lysates and compared the results combined with diﬀerent
LC-MS techniques. We identiﬁed the isolated kinases by
performing gene ontology mapping of all identiﬁed proteins
and then searching in the term “molecular function” for
kinases. The number of kinases identiﬁed in the various
setupsandthenumberofthecorrespondinguniquepeptides
and unique spectra are illustrated as Venn diagrams in
Figure 2. Across all experiments, 101 kinases were identiﬁed;
however,threeofthesewereonlydetectedinthecompetition
experiments and therefore rejected. Out of the remaining
98 kinases, only 7 kinases were exclusively identiﬁed in 1D
LC experiments. The number of identiﬁed kinases in the
capture assays increased from 23 to 39 to 91 out of the
total number of proteins from 386 to 617 to 1274 when
comparing 90min gradient 1D LC to 180min gradient 1D
LC to 2D LC experiment (Table 1 and Supplementary Table).4 Journal of Biomedicine and Biotechnology
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Figure 2: Venn-diagrams of kinases (with ≥2 peptides) (a), peptides (b), spectra (c) derived from each two technical replicates: 1D LC-MS
(90 and 180min gradient and 2D LC-MS).
Table 1: Proteins and kinases identiﬁed in the diﬀerent LC-MS set-ups.
Total number of identiﬁed
proteins in capture assays
(with ≥2p e p t i d e s )
Kinases identiﬁed in capture assays
(with ≥2p e p t i d e s )
Number of competed kinases∗
(with ≥2p e p t i d e s )
1D LC-MS 90min 386 (158) 23 (10) 20 (8)
1D LC-MS 180min 617 (265) 39 (19) 31 (16)
2D LC-MS 1274 (489) 91 (48) 66 (32)
∗A kinase is considered to be competed if the number of spectral counts in the capture assay divided by number of spectral counts in the competition control
is ≥2 or the number of spectral counts in the competition is = 0.
This represents at least 38% of the 253 kinases that have
been reported to be targeted by staurosporine [4] and not
all of which may be expressed in HepG2 cells. The identiﬁed
kinases cover a broad functional range and are representative
for the diﬀerent classes of kinases.
Among the 98 kinases identiﬁed the majority are mem-
bers of the serine/threonine kinase family (36) followed
by small molecule kinases (28). Furthermore, 34 kinases
belonging to the tyrosine kinase family such as proto-
oncogene kinases and dual-speciﬁc kinases were identiﬁed.
Comparison of the capture assays with the competition
controls distinguished speciﬁc interactors of staurosporine
from unspeciﬁc background. We deﬁned an interaction to
be speciﬁc if the protein was exclusively present, or with
twice as many spectral counts in the capture assay than
in the competition control (Table 1). Approximately, two-
thirds of the kinases (66) identiﬁed in the 2D LC-MS runs
were speciﬁcally enriched. The remaining kinases mainly
havemetabolicfunctionsuchasbifunctionalATP-dependent
dihydroxyacetone kinase (DHAK) or 6-phosphofructokinase
(K6PL). These kinases are highly expressed and can also be
detected in shotgun experiments without prior enrichment
as previously shown [1].
Out of a total number of 1274 proteins, 144 non-
kinases were also speciﬁcally enriched performing the 2D
LC-MS; these can be mainly classiﬁed into three groups:
ATP-binding proteins, detoxiﬁcation enzymes, and nucleic
acid-bindingproteins.ThemajorityisATP-bindingproteins,
which is plausible, as staurosporine is an ATP mimetic
kinase inhibitor. The most highly enriched non-kinase
protein with a fold change of 2.8 between the assay and
the competition analyzed by 2D LC-MS was the nucleic
acid-binding FUBP2; the next following are the two ATP-
binding proteins ACACA and PCCA. These non-kinase
target proteins of staurosporine can shed light on additional
pathways disturbed when using staurosporine as kinase
inhibitor, for example, in cell-based assays.
4. Discussion
The results presented in this study demonstrate that combi-
ning CCMS technology with 2D LC-MS enables identiﬁ-
cation of enriched kinases with enhanced conﬁdence and
muchloweramountsofinputmaterial.Inourpreviousstudy
[1], using 1D LC-MS, eight experiments were needed to
obtain nearly as much enriched kinases, and consequently
four times as many capture experiments (each set of assay
andcompetitionrequiringapproximatelyoneworkday)were
needed requiring four times as much input material, while
the overall MS analyses time remained comparable. There
are alternative approaches for the comprehensive proﬁling
of the kinome published: the most successful is the use
of multi-inhibitor beads that address a very large range of
kinases ([5], “kinobeads”). We were therefore also interested
to use the stauro-CC in such a solid support approach. In
previous studies [6, 7] using other Capture Compounds we
also used a second experimental setup termed “On-bead
CCMS conﬁguration” and obtained results complementing
the oﬀ-bead setup presented here. (on-bead: CCs are ﬁrst
immobilized on beads, then added to protein mixture and
irradiated, oﬀ-bead: CCs are ﬁrst added to protein mixture,Journal of Biomedicine and Biotechnology 5
irradiated and then isolated via magnetic beads). Using the
stauro-CCintheon-beadconﬁguration,however,nokinases
were enriched and identiﬁed. Possibly the hydrophobic stau-
rosporineselectivityfunctionburiesitselfinthehydrophobic
bead surface, or the beads disturb the photoreaction for this
particular Capture Compound. In the case of the kinobeads,
seven diﬀerent kinase inhibitors are covalently attached to a
solid support to create aﬃnity chromatography material for
kinase binding. With these kinobeads, 269 human kinases
couldbeisolatedfromatotalofsixdiﬀerentcelllinesandtwo
humantissues.Upto25mgoftotalproteinwasusedasinput
for the aﬃnity pulldown experiments. Another successful
studyhasbeenpublishedbyOppermannetal.[8].Thisstudy
isbasedonkinaseinhibitoraﬃnitychromatographybeadsas
well, in this case with a single inhibitor attached to a solid
support. From sample sized 1.5mg protein of lysate each,
a total of 170 kinases were identiﬁed across three diﬀerent-
cultured cancer cell lines. Samples of aﬃnity-puriﬁed target
proteins were analyzed after fractionation via SDS-PAGE.
The Capture Compound approach has been optimized
as a method for biological samples of limited abundance
such as tissue biopsies. Therefore, our workﬂow is designed
for relatively small volumes (such as 100μL) containing
moderate amounts of protein mixture (∼400μg per assay).
This is roughly a quarter of the material used by Oppermann
et al., and less than 2% of the material used by Bantscheﬀ
e ta l .I nt h i ss t u d y ,w ew e r ea b l et od e m o n s t r a t eu s i n ge v e n
less input material and still raise the overall number of
speciﬁcally enriched proteins. The rationale behind that is
that we want to establish our assay in an as robust and simple
and straightforward way as possible.
5. Conclusions
Using staurosporine as selectivity function, a broad range of
kinases belonging to diﬀerent pathways could be identiﬁed.
As a unique feature, the photoreactivity group forms a
covalent bond between the Capture Compound and the
captured kinases, so that even weak interactors of the
selectivityfunctionarecovalentlyattachedallowingstringent
washing conditions. This allows endogenous low-aﬃnity
and low-abundant proteins to be isolated and identiﬁed by
CCMS. Our results demonstrate that CCMS is a powerful
new technology for the investigation of kinases, and its
investigative power can be even enhanced when combined
with two-dimensional liquid chromatography connected to
a high scan speed mass spectrometer for a better separation
and detection of the digested peptides resulting in a higher
number of identiﬁed proteins and more conﬁdent results.
Our ﬁndings open a perspective for CCMS as tool for
charting kinases in the postgenome area and in biomarker
discovery and research.
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